AbbVie Inc. (ABBV) vs The Coca-Cola Company (KO)
A side-by-side comparison of AbbVie Inc. and The Coca-Cola Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ABBV is classified in Healthcare; KO is classified in Consumer Defensive. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ABBV
AbbVie Inc.
$261.70HealthcareDelayed quote: Sep 14, 2026, 3:59 PM EDT
KO
The Coca-Cola Company
$89.37Consumer DefensiveDelayed quote: Sep 14, 2026, 3:59 PM EDT
Total return — ABBV vs KO
growth of $100 · dividends reinvested · last 10yABBV +512.1% (+19.9%/yr)KO +176.5% (+10.7%/yr)ABBV compounded faster over this window
ABBV KO
ABBV vs KO: by the numbers
- •ABBV is the larger company ($462.37B vs $384.50B market cap).
- •KO trades at the lower trailing earnings multiple (26.84 vs 73.73 P/E), one valuation lens rather than an overall verdict.
- •KO converts more revenue to profit (28.56% vs 9.81% net margin).
- •KO grew revenue faster over the past five years (6.60% vs 3.69% CAGR).
- •ABBV pays the higher dividend yield (2.66% vs 2.36%).
Metrics side by side
Valuation
| Metric | ABBV | KO |
|---|---|---|
| P/E ratio | 73.73 | 26.84 |
| Forward P/E | 18.63 | 27.04 |
| P/S ratio | 7.18 | 7.67 |
| P/B ratio | N/A | 10.64 |
| EV / EBITDA | 19.65 | 26.13 |
| FCF yield | 3.92% | 3.72% |
Profitability
| Metric | ABBV | KO |
|---|---|---|
| Gross margin | 71.48% | 61.89% |
| Operating margin | 29.32% | 29.63% |
| Net margin | 9.81% | 28.56% |
| ROE | N/A | 39.60% |
| ROIC | 13.46% | 13.91% |
Dividends
| Metric | ABBV | KO |
|---|---|---|
| Dividend yield | 2.66% | 2.36% |
| Payout ratio | 192.43% | 62.46% |
Growth (annualized)
| Metric | ABBV | KO |
|---|---|---|
| Revenue CAGR (5Y) | 3.69% | 6.60% |
| EPS CAGR (5Y) | -2.79% | 11.12% |
| FCF CAGR (5Y) | 0.11% | -9.38% |
| Total return CAGR (5Y) | 23.70% | 12.98% |
Frequently asked
- Which has the lower trailing P/E, ABBV or KO?
- KO has the lower trailing P/E: ABBV trades at 73.73 and KO at 26.84. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or KO?
- Over the past five years, KO grew revenue faster — ABBV at a 3.69% CAGR versus KO at 6.60%.
- Does ABBV or KO pay a bigger dividend?
- ABBV yields 2.66% and KO yields 2.36% based on trailing dividends and the latest price.
- Is ABBV or KO more profitable?
- KO runs the higher net margin — ABBV at 9.81% versus KO at 28.56%.
- How have ABBV and KO total returns compared?
- Over the past 10 years, ABBV delivered 19.85% and KO delivered 11.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioCoca-Cola P/E ratioAbbVie dividend yieldCoca-Cola dividend yieldAbbVie ROECoca-Cola ROEAbbVie operating marginCoca-Cola operating marginAbbVie revenue growthCoca-Cola revenue growthAbbVie free cash flowCoca-Cola free cash flow
AbbVie & Coca-Cola appear in these rankings
Highest Dividend Yield Stocks25+ Year Dividend GrowersHighest ROE StocksHighest 10-Year Total Return Stocks
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.